Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Marcia da Silva Cardoso"'
Publikováno v:
Transfusion and Apheresis Science. 57:683-688
Blood transfusion safety has been increasingly improving during the past two decades. However, threats from both known and emerging pathogens require continual improvement and re-assessment of blood safety measures. In this respect, we are currently
Autor:
Marcia da Silva Cardoso, Remy Jacob, Fanette Defraigne, Anne Schuhmacher, Aicha Bah, Nicolas Malvaux
Publikováno v:
Transfusion and Apheresis Science. 60:103195
In 2014–2015, the Luxembourg Red Cross (LRC) implemented a fully automated system (FAS) able to process 4 whole blood units simultaneously, and a pathogen reduction technology (PRT) based on riboflavin and ultraviolet light to improve safety of pla
Publikováno v:
TransfusionREFERENCES. 60(7)
Pathogen inactivation/reduction technologies for platelet components have been developed to enhance microbial safety, and many studies have been carried out to determine whether this technique adversely affects the platelet's ability to stop or preve
Autor:
Aleksandra Rosiek, Magdalena Łętowska, Lech Rzymkiewicz, Elżbieta Lachert, Zofia Przybylska, Dariusz Piotrowski, Marcia da Silva Cardoso
Publikováno v:
Transfusion. 56:S39-S44
Background In 2009 the Mirasol Pathogen Reduction Technology (PRT) was introduced to the routine blood component production of the Regional Blood Transfusion Center in Warsaw (RBTCW). The goal of this study was to investigate the safety of Mirasol-tr
Publikováno v:
B Group Vitamins-Current Uses and Perspectives
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca58fe817c6db069d016db8d7ab9798d
http://www.intechopen.com/articles/show/title/vitamin-b2-and-innovations-in-improving-blood-safety
http://www.intechopen.com/articles/show/title/vitamin-b2-and-innovations-in-improving-blood-safety
Autor:
Cornelia Lenz, K. Koerner, Bernhard Kubanek, Marcia da Silva Cardoso, S. Prokein, A. Schwandt, Wibke Hinz, B. Rau
Publikováno v:
Biologicals. 27:281-284
In this report we present the accumulated data on nucleic acid testing (NAT) for hepatitis C virus (HCV) RNA of blood donations by the Blood Transfusion Service of Baden-Württemberg in the period between March 1997 and March 1999. An extra barcoded
Publikováno v:
Vox Sanguinis. 74:213-216
Objective: The risk of transmitting hepatitis C (HCV) by transfusion of anti-HCV-negative screened blood was estimated for the blood donor population of Baden-Wurttemberg (southwestern Germany). Methods: The data from the blood donors screened for an
Publikováno v:
European Journal of Epidemiology. 10:637-640
In this study we compared the nucleotide sequence of the 5' NC-region of the HCV genome isolated from seven patients and two blood donors from Southern Germany. We could identify two very distinct groups of isolates: the first very similar to the HCV
Publikováno v:
Hybridoma. 13:9-13
In this study we describe the establishment of two hybridoma cell lines secreting human monoclonal antibodies to the 22-kD nucleocapsid protein (core, p22) of the hepatitis C virus (HCV). For this purpose we isolated B lymphocytes from an anti-HCV po
Publikováno v:
Vox Sanguinis. 67:154-159
Three different synthetic media without glucose were studied for platelet storage. The first medium contained acetate and gluconate. The second contained acetate, gluconate and citrate. Finally the third contained phosphate and mannitol. The purpose